New transplant method aims to cure blood diseases with fewer complications
NCT ID NCT01174108
Summary
This study is testing a modified stem cell transplant procedure for people with severe blood disorders like aplastic anemia. Researchers are adjusting how donor cells are collected and given to try to reduce serious side effects while still successfully replacing the patient's faulty bone marrow. Participants receive donor stem cells along with medications to prevent rejection, and are followed for up to 3 years to see if this approach works better than standard transplants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland, Baltimore (UMB)
COMPLETEDBaltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.